Makers of insulin delivery systems, Tandem Diabetes Care (NASDAQ:TNDM) and Insulet (NASDAQ:PODD), marked a contrasting stock ...

Tandem Diabetes reports record Q2 2025 sales, progressing toward $1B goal. Learn about product advances, pharmacy expansion, and international growth.

Tandem Diabetes Care sent an ‘Urgent Medical Device Correction’ letter regarding possible speaker failure and pump delivery failure.

Tandem Diabetes Care issued a voluntary correction for an insulin pump model due to a speaker malfunction that disrupts communication with glucose monitoring systems, potentially causing high blood ...

Tandem Diabetes (TNDM) faces setbacks with a downgrade from Piper Sandler, demand challenges, and device corrections impacting its stock. Read more here.

The shift is part of a larger regionalization strategy to bring production of HVAC components closer to customers in the Americas by investing in local manufacturing, reducing lead times and ...

The insulin pump landscape is primarily dominated by a few major players with global reach, including Medtronic, Insulet, and Tandem Diabetes Care.

Tandem Diabetes Care: Offers t:slim X2 insulin pump with Control-IQ technology, integrating CGM and automated insulin delivery.

The global insulin pump market, valued at USD 4.31 billion in 2024, is projected to soar to USD 7.27 billion by 2030 with a CAGR of 9.10% due to rising diabetes cases and technological advances. In ...

Contamination blocking the jet pump orifices of the suspect low-pressure fuel pumps may result in an unexpected engine stall while driving ...

UK and France agree nuclear weapons can be used in tandem to deter Russia France and Britain are the only two nuclear powers in Europe.

South West Skydive company closes down after tandem jump deaths The company is to be put into compulsory liquidation News By ...